Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Well, I think a deal is coming because one is obviously needed to distribute in the EU, and I am guessing that ADXS has more leverage now. A $10-$15m milestone for NEO dosing would help. There would be no basis for a lawsuit if Lombardo signs a deal in a couple of weeks/months. His justification would simply be that until a deal is signed he had no choice but to fund the company with an offering. Particularly in light of the possibility that additional shares might not be authorized. With only 15 million shares left and a ridiculously suppressed stock he could not take the chance that the company wouldn’t make it until the following year’s shareholder meeting. In other words, that he had no choice. And any experienced CFO or banker would probably agree.